Let's discuss how Daly Innovations can provide product development guidance
Let's TalkDaly Innovations helps life-science and med-tech teams move from concept to commercialisation — combining R&D strategy, programme management, and scale-up execution into one integrated, hands-on support model.
We partner with startups, SMEs, and investors to de-risk complex product development across instruments, consumables, and reagents.
Align scientific ambition with commercial reality. We translate ideas into investable roadmaps with clear stage-gates, resources, and measurable outcomes.
Hands-on leadership and governance for complex, multi-disciplinary programmes — coordinating engineering, biology, regulatory, suppliers, and manufacturing.
Move from prototype to production with confidence.
"Working with Daly Innovations accelerated our product launch by 6 months."
"Their strategic guidance tripled our development speed."
"Daly Innovations helped us align our project portfolio with market needs."
John Daly Ph.D., is the CEO of Daly Innovations. He holds a B.Eng in Aeronautical Engineering and a Ph.D. in Biotechnology from the University of Limerick, Ireland. His doctoral work was patented and contributed to Stokes Bio Ltd, later acquired by Life Technologies.
John has held significant research and leadership roles, including at Bell Labs (Nokia) and as CTO at GenCell Biosystems, acquired by Becton Dickinson. At BD GenCell, he secured 250 new jobs and expanded research facilities.
Since 2017, John led Curran Scientific as CEO, helping clients to drive innovation and scientific advancement. John was involved in multiple DTIF projects. John now leads Daly Innovations, a contract and consultancy specialising in Life Sciences.
Let's transform your innovation challenges into competitive advantages.
Get in TouchReady to discuss your innovation challenges? Reach out today.
Email: john@dalyinnovations.com